Skip to content
10-Q

Quarterly Report

JUNIPER PHARMACEUTICALS INC

0001564590-18-012960

← back to feed
Filed
May 10, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2018 · May 3, 2018 11.1M sh
Shares Diluted Q1 2018 · Mar 31, 2018 12.29M sh
Shares Diluted Q1 2018 · Mar 31, 2017 10.8M sh
Capex Q1 2018 · Mar 31, 2018 $875K
Capex Q1 2018 · Mar 31, 2017 $520K
Cash And Equivalents Q1 2018 · Mar 31, 2018 $20.69M
Cash And Equivalents Q1 2018 · Dec 31, 2017 $21.45M
Cash And Equivalents Q1 2018 · Mar 31, 2017 $21.76M
Cash And Equivalents Q1 2018 · Dec 31, 2016 $20.99M
Stockholders Equity Q1 2018 · Mar 31, 2018 $51.02M
Stockholders Equity Q1 2018 · Dec 31, 2017 $41.51M
Current Liabilities Q1 2018 · Mar 31, 2018 $10.2M
Current Liabilities Q1 2018 · Dec 31, 2017 $16.34M
Total Liabilities Q1 2018 · Mar 31, 2018 $13.52M
Total Liabilities Q1 2018 · Dec 31, 2017 $19.71M
Current Assets Q1 2018 · Mar 31, 2018 $38.42M
Current Assets Q1 2018 · Dec 31, 2017 $35.97M
Total Assets Q1 2018 · Mar 31, 2018 $64.54M
Total Assets Q1 2018 · Dec 31, 2017 $61.22M
Eps Diluted Q1 2018 · Mar 31, 2018 $0.06
Eps Diluted Q1 2018 · Mar 31, 2017 −$0.13
Eps Basic Q1 2018 · Mar 31, 2018 $0.07
Eps Basic Q1 2018 · Mar 31, 2017 −$0.13
Sga Expense Q1 2018 · Mar 31, 2018 $4.09M
Sga Expense Q1 2018 · Mar 31, 2017 $4.42M
Rd Expense Q1 2018 · Mar 31, 2018 $974K
Rd Expense Q1 2018 · Mar 31, 2017 $1.35M
Net Income Q1 2018 · Mar 31, 2018 $772K
Net Income Q1 2018 · Mar 31, 2017 −$1.44M
Operating Income Q1 2018 · Mar 31, 2018 $1.02M
Operating Income Q1 2018 · Mar 31, 2017 −$1.46M
Gross Profit Q1 2018 · Mar 31, 2018 $6.5M
Gross Profit Q1 2018 · Mar 31, 2017 $4.69M
Cost Of Revenue Q1 2018 · Mar 31, 2018 $9.03M
Cost Of Revenue Q1 2018 · Mar 31, 2017 $6.56M
Revenue Q1 2018 · Mar 31, 2018 $15.52M
Revenue Q1 2018 · Mar 31, 2017 $11.25M
Dividends Paid Q1 2018 · Mar 31, 2017 $7K